Yue Cai
Impact in
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- Colorectal Cancer Surgical Treatments
- Colorectal Cancer Treatments and Studies
- Drug Transport and Resistance Mechanisms
- Cancer Cells and Metastasis
Papers in
- Co-authors
- Xuanrong Sun (25 shared papers)Yanhong Deng (39 shared papers)Jianwei Zhang (29 shared papers)Jiayu Ling (21 shared papers)Huabin Hu (32 shared papers)Zehua Wu (20 shared papers)Jianxia Li (13 shared papers)Yan Huang (5 shared papers)
- Journals
- Journal of Clinical Oncology (17 papers)European Journal of Medicinal Chemistry (4 papers)Molecules (3 papers)International Journal of Nanomedicine (2 papers)Drug Delivery (2 papers)
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Yue Cai
83 papers receiving 1.3k citations
Yue Cai's Hit Papers
Peers
Comparison fields: 5 of 96
- Oncology 441
- Cancer Research 135
- Biomaterials 128
- Pharmaceutical Science 52
- Molecular Biology 443
Countries citing papers authored by Yue Cai
This map shows the geographic impact of Yue Cai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yue Cai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yue Cai more than expected).
Fields of papers citing papers by Yue Cai
This network shows the impact of papers produced by Yue Cai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yue Cai. The network helps show where Yue Cai may publish in the future.
Co-authors
The 25 scholars most cited alongside Yue Cai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 86 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Remodeling of the immune and stromal cell compartment by PD-1 blockade in mismatch repair-deficient colorectal cancer Hit paper breakdown → | 2023 | 208 |
| 2 | 2018 | 75 | |
| 3 | 2020 | 56 | |
| 4 | 2013 | 50 | |
| 5 | 2022 | 49 | |
| 6 | 2015 | 41 | |
| 7 | 2019 | 37 | |
| 8 | 2017 | 36 | |
| 9 | 2023 | 34 | |
| 10 | 2015 | 34 | |
| 11 | 2019 | 31 | |
| 12 | 2013 | 30 | |
| 13 | 2022 | 29 | |
| 14 | Sorafenib inhibits liver cancer growth by decreasing mTOR, AKT, and PI3K expression. | 2015 | 27 |
| 15 | 2023 | 26 | |
| 16 | 2020 | 26 | |
| 17 | 2021 | 26 | |
| 18 | 2021 | 25 | |
| 19 | 2020 | 23 | |
| 20 | 2019 | 21 |
About Yue Cai
Yue Cai is a scholar working on Oncology, Surgery, Molecular Biology, Pulmonary and Respiratory Medicine and Biomaterials, having authored 86 papers that have together received 1.3k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (20 papers), Colorectal Cancer Surgical Treatments (15 papers), Colorectal and Anal Carcinomas (11 papers), Nanoparticle-Based Drug Delivery (8 papers), Drug Transport and Resistance Mechanisms (6 papers), RNA Interference and Gene Delivery (5 papers), Gastric Cancer Management and Outcomes (5 papers) and Genetic factors in colorectal cancer (5 papers). The work is most often cited by research in Oncology (441 citations), Cancer Research (135 citations), Biomaterials (128 citations), Pharmaceutical Science (52 citations) and Molecular Biology (443 citations). Yue Cai has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Xuanrong Sun, Yanhong Deng, Jianwei Zhang, Jiayu Ling, Huabin Hu, Zehua Wu, Jianxia Li, Yan Huang, Rong Xu and Sisi Cao. Their work appears in journals such as Journal of Clinical Oncology, European Journal of Medicinal Chemistry, Molecules, International Journal of Nanomedicine and Drug Delivery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.